E2F6/KDM5C promotes SF3A3 expression and bladder cancer progression through a specific hypomethylated DNA promoter
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
E2F6/KDM5C promotes SF3A3 expression and bladder cancer progression through a specific hypomethylated DNA promoter
Authors
Keywords
-
Journal
Cancer Cell International
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-05
DOI
10.1186/s12935-022-02475-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CDK13 upregulation-induced formation of the positive feedback loop among circCDK13, miR-212-5p/miR-449a and E2F5 contributes to prostate carcinogenesis
- (2021) Jin-Chun Qi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer
- (2021) Maciej Cieśla et al. MOLECULAR CELL
- The Dual Function of KDM5C in Both Gene Transcriptional Activation and Repression Promotes Breast Cancer Cell Growth and Tumorigenesis
- (2021) Hai‐feng Shen et al. Advanced Science
- circACTA2 mediates Ang II-induced VSMC senescence by modulation of the interaction of ILF3 with CDK4 mRNA
- (2021) Ying Ma et al. Aging-US
- Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway
- (2021) Li-Xin Ren et al. Cancer Cell International
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Further delineation of the female phenotype with KDM5C disease causing variants: 19 new individuals and review of the literature
- (2020) Virginie Carmignac et al. CLINICAL GENETICS
- Treatment of muscle‐invasive and advanced bladder cancer in 2020
- (2020) Vaibhav G. Patel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect
- (2020) Jiansong Han et al. BIOMEDICINE & PHARMACOTHERAPY
- KDM5c Promotes Colon Cancer Cell Proliferation Through the FBXW7-c-Jun Regulatory Axis
- (2020) Haishan Lin et al. Frontiers in Oncology
- Bladder Cancer
- (2020) Andrew T. Lenis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Systematic Analyses of the Role of the Reader Protein of N6-Methyladenosine RNA Methylation, YTH Domain Family 2, in Liver Hepatocellular Carcinoma
- (2020) Xiang-yang Shao et al. Frontiers in Molecular Biosciences
- KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN
- (2019) Zhe Hong et al. BIOMEDICINE & PHARMACOTHERAPY
- Upregulation of NPL4 promotes bladder cancer cell proliferation by inhibiting DXO destabilization of cyclin D1 mRNA
- (2019) Bao-Sai Lu et al. Cancer Cell International
- Structure of the human activated spliceosome in three conformational states
- (2018) Xiaofeng Zhang et al. CELL RESEARCH
- Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China
- (2018) Peng Wu et al. Frontiers in Cellular and Infection Microbiology
- KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1
- (2018) Haishan Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- KDM5 demethylases and their role in cancer cell chemoresistance
- (2018) J. Plch et al. INTERNATIONAL JOURNAL OF CANCER
- Structures of the human pre-catalytic spliceosome and its precursor spliceosome
- (2018) Xiechao Zhan et al. CELL RESEARCH
- T1 bladder cancer: current considerations for diagnosis and management
- (2018) Brian Jordan et al. Nature Reviews Urology
- Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway
- (2018) Zhan Yang et al. ONCOGENE
- Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
- (2017) Zhan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor vesical: presente y futuro
- (2017) Roberto Hugo Martinez Rodriguez et al. MEDICINA CLINICA
- Treatment of muscle-invasive bladder cancer: A systematic review
- (2016) Roger Chou et al. CANCER
- DNA Methylation in Cancer and Aging
- (2016) M. Klutstein et al. CANCER RESEARCH
- RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML
- (2016) Leslie A. Crews et al. Cell Stem Cell
- Cellular stress response 1 down-regulates the expression of epidermal growth factor receptor and platelet-derived growth factor receptor through inactivation of splicing factor 3A3
- (2016) Ze-Hua Zuo et al. MOLECULAR CARCINOGENESIS
- An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
- (2016) Maia Vinogradova et al. Nature Chemical Biology
- miR-155-dependent regulation of mammalian sterile 20-like kinase 2 (MST2) coordinates inflammation, oxidative stress and proliferation in vascular smooth muscle cells
- (2015) Zhan Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
- (2015) Cheryl M. Koh et al. NATURE
- Structure and assembly of the SF3a splicing factor complex of U2 snRNP
- (2012) Pei-Chun Lin et al. EMBO JOURNAL
- Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers
- (2012) S. Seisenberger et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer
- (2011) B. Stefanska et al. CANCER RESEARCH
- Epigenetics of kidney cancer and bladder cancer
- (2011) Amanda M Hoffman et al. Epigenomics
- Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger
- (2009) Gang G. Wang et al. NATURE
- Epigenetics in bladder cancer
- (2008) Hideki Enokida et al. International Journal of Clinical Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started